Aurorium的动态

New study, "Beyond the Prescription," by MAGNA Media Trials, in partnership with DeepIntent, reveals that pharmaceutical ads significantly influence patient behavior and health management. Key findings show that 63% of patients learn about new medications from these ads, and 55% discover new health conditions thanks to them. Learn more about the impact of pharmaceutical ads here: https://lnkd.in/eZJUUFQE

Looking to cut pharmacy costs for your employees? ?? Biosimilars could be the answer! Despite biologics making up 46% of pharmaceutical spending, they're just 2% of prescriptions. Educate your employees about the cost-saving potential of biosimilars and help them unlock significant healthcare savings. Spread the word and share this vital article with them today! ?? #Biosimilars #HealthcareSavings #PharmacyCosts https://lnkd.in/gJWFtnSW

Read our latest article in the 340B Report: The Evolving Impact of 340B on Specialty Pharmacy: Opportunities and Challenges by William Riley. Learn how the current state of the #340B program intersects with specialty pharmacy as well as the opportunities and challenges stakeholders face. #Protect340B #SpecialtyPharmacy

In the ever-evolving landscape of pharmaceutical supply chains, timely delivery of life-saving treatments remains critical to ensuring patients receive vital medications. ?? However, intricate challenges and emerging trends are shaping the supply chain landscape, adding new layers of complexity that manufacturers must overcome. ?? In our recent piece with Pharmaceutical Outsourcing, Thomas P Wilson, Global Contract Manufacturing Leader at Pfizer CentreOne, discusses the strategies that can be applied to navigate current supply chain trends and outlines the importance of having these in place to overcome challenges on the horizon. Read more ?? https://lnkd.in/ettVz496 #CDMO #Pharma#PharmaSupplyChain #CDMO

what we do

In today’s globalized world, the pharmaceutical industry faces unprecedented challenges and opportunities in distributing its products across international markets. As healthcare needs continue to evolve and expand worldwide, pharmaceutical companies must navigate a complex web of regulations, supply chain intricacies, and market-specific demands to ensure their life-saving medications reach patients efficiently and safely. https://lnkd.in/ertzt63p

The Evolving Impact of 340B on Specialty Pharmacy - https://lnkd.in/eCyrvR6f SPONSORED CONTENT The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty medications become an increasing portion of healthcare [...] #340B

When one leading pharmaceutical company in Europe experienced a lack of global oversight due to inconsistent medical information management approaches across affiliates, they turned to LifeSphere Medical Information. Discover the transformational outcomes they experienced by implementing LifeSphere Medical Information on the blog: https://lnkd.in/eu643sU5 #medicalinformationmanagement #arisglobal #pharmatech

Discover the latest trends in pharmaceutical packaging that prioritize safety and convenience. Our new article highlights the significance of unit-dose packs and tamper-evident seals, illustrating how they're elevating patient experiences and maintaining the highest standards in medication safety and integrity. Read More: https://lnkd.in/ew_iJj3X #DistinctiveSolutions #PharmaPackaging #CustomPackaging #ColdChainPackaging

Using generic names for prescriptions can promote healthy competition in the pharmaceutical industry by making medications more accessible and affordable. Generic drugs are typically less expensive than brand-name counterparts, which can lead to significant savings for patients and healthcare systems. Additionally, this approach can help reduce the influence of pharmaceutical companies on prescribing practices, minimizing potential conflicts of interest. Encouraging doctors to focus on generic names fosters a culture of patient-centered care and emphasizes the importance of efficacy over branding. Ultimately, prioritizing generics can enhance healthcare equity and patient outcomes. #bangladesh